AMPH vs DGX · P/E 12, rev $355.1M vs P/E 22, rev $5.94B
Amphastar P (AMPH) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported AMPH revenue for 2026-06-30 was $355.1M. Net income was $36.8M. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the AMPH and DGX stock pages for the full models.
Not investment advice.